BIOMAT Database Logo BIOMAT Database Logo

Potential dangers in the combined use of methandrostenolone and sodium warfarin. 1967

F C Dresdale, and J C Hayes

UI MeSH Term Description Entries
D008696 Methandrostenolone A synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1188) Dehydromethyltestosterone,Metandienone,Methandienone,Dianabol,Metanabol,Nerobol
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

F C Dresdale, and J C Hayes
Metabolism of warfarin during methandrostenolone treatment.
January 1965, Annales medicinae experimentalis et biologiae Fenniae,
F C Dresdale, and J C Hayes
COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.
July 1964, JAMA,
F C Dresdale, and J C Hayes
[Use of methandrostenolone in the combined treatment of iron-deficiency anemia patients].
November 1983, Vrachebnoe delo,
F C Dresdale, and J C Hayes
Warfarin: dangers with antibiotics.
October 1993, Dental update,
F C Dresdale, and J C Hayes
Potential interaction between warfarin sodium and fluoxetine.
November 1991, The American journal of psychiatry,
F C Dresdale, and J C Hayes
Potential dangers of accelerant use in arson.
February 2011, Journal of forensic and legal medicine,
F C Dresdale, and J C Hayes
Potential dangers in the uncontrolled use of shoe-fitting fluoroscopes.
September 1949, The New England journal of medicine,
F C Dresdale, and J C Hayes
[Use in dermatology of the dexamethasone-methandrostenolone combination].
March 1962, La Semana medica,
F C Dresdale, and J C Hayes
Barriers to the use of warfarin: potential solutions.
January 2004, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,
F C Dresdale, and J C Hayes
USE OF METHANDROSTENOLONE IN CHRONIC SCHIZOPHRENIC PATIENTS.
March 1964, Diseases of the nervous system,
Copied contents to your clipboard!